SYNLAB Belgium
SYNLAB Belgium has a large number of establishment units without filed annual accounts in our source; for such large operators Checked does not compute a reliable bankruptcy probability. The company has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 32 yrs |
| Board | 1 |
| Locations | 85 |
| Publications | 27 |
This is a large operator with many establishment units but no filed annual accounts in our source. A reliable estimate is not possible for such companies right now, so we'd rather not show a number.
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | ander | 30-08-2025 | 2025-00471791 |
| 31-12-2023 | ander | 18-07-2024 | 2024-00265053 |
| 31-12-2022 | ander | 29-08-2023 | 2023-00406953 |
| 31-12-2021 | ander | 20-07-2022 | 2022-20248485 |
| 31-12-2020 | ander | 18-08-2021 | 2021-50500408 |
| 31-12-2019 | volledig | 21-09-2020 | 2020-54800390 |
| 31-12-2018 | volledig | 27-08-2019 | 2019-53800454 |
| 31-12-2017 | volledig | 29-08-2018 | 2018-56000483 |
| 31-12-2016 | volledig | 19-07-2017 | 2017-34200454 |
| 31-12-2015 | volledig | 27-06-2016 | 2016-22800208 |
-
Current12-04-2023 → present
Historic, not recently confirmed (4)
-
Not recently confirmedlast confirmed in an act from 2015
-
Not recently confirmedlast confirmed in an act from 2015
-
Not recently confirmedlast confirmed in an act from 2013
-
Not recently confirmedlast confirmed in an act from 2013
Former directors (9)
-
Former13-09-2021 → 10-05-2022
2 events
- 10-05-2022 Resigned· Director
- 13-09-2021 Appointed· Director
-
Former01-12-2017 → 15-12-2020
2 events
- 15-12-2020 Resigned· Director
- 01-12-2017 Appointed· Managing director
-
Former27-07-2017 → 15-12-2020
2 events
- 15-12-2020 Resigned· Director
- 27-07-2017 Appointed· Manager
-
Former- → 01-12-2017
-
Former30-11-2014 → 01-07-2017
2 events
- 01-07-2017 Resigned· Managing director
- 30-11-2014 Appointed· Managing director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| SRL DELOITTE Réviseurs d'EntreprisesCurrent Statutory auditor · represented by Carl LASCHET |
- | 03-11-2025 → present |
Show 4 earlier auditors
| BDO Réviseurs d'Entreprises Statutory auditor · represented by Michel Grignard |
- | - → 26-05-2013 |
| Deloitte Réviseurs d'entreprises S.C. SRL Statutory auditor · represented by Carl Laschet succeeded by SRL DELOITTE Réviseurs d'Entreprises in 2025 |
- | 10-02-2023 → 03-11-2025 |
| Ernst & Young Bedrijfsrevisoren BCVBA Statutory auditor · represented by Marie-Laure Moreau succeeded by SCRL Deloitte Réviseurs d'Entreprises in 2016 |
- | 28-06-2013 → 24-06-2016 |
| SCRL Deloitte Réviseurs d'Entreprises Statutory auditor · represented by Julie Delforge succeeded by Deloitte Réviseurs d'entreprises S.C. SRL in 2023 |
- | 24-06-2016 → 10-02-2023 |
| NACE primary | Activiteiten van medische beeldvorming en medische laboratoria(86910) |
| Legal form | Private limited company(610) |
| Incorporation | 17-06-1994 |
| Status | Active |
| Postal code | 6220 |
Show 79 more locations
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52032B0080/00F000 | Wallonia | 4.0 ha | 1 · 2,916 m² | 9.3 m · 3 fl. |
| 81005F0054/00E000 | Wallonia | 1.6 ha | - | - |
| 61322A1480/00E000 | Wallonia | 9,597 m² | 1 · 278 m² | - |
| 22552E0048/00Z025 | Flanders | 7,308 m² | 1 · 1,453 m² | 23.0 m · 4 fl. |
| 62038B0054/00F000 | Wallonia | 7,069 m² | 1 · 1,021 m² | 14.6 m · 2 fl. |
| 62087B0295/00K002 | Wallonia | 5,328 m² | 1 · 886 m² | 11.5 m · 3 fl. |
| 21342B0079/00N000 | Brussels | 4,697 m² | 1 · 2,186 m² | 23.1 m · 6 fl. |
| 62815D0283/00A000 | Wallonia | 3,387 m² | 1 · 214 m² | 6.0 m · 1 fl. |
| 63040A0034/03_000 | Wallonia | 2,701 m² | - | - |
| 62104A0345/00S000indicative | Wallonia | 2,678 m² | 1 · 125 m² | 5.7 m |
62 more parcels, available from Kantoor S.
See plans →A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 34 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
03-11-2025 Carl LASCHET reappointed as statutory auditor
- Carl LASCHET, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Carl LASCHET",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SRL Deloitte R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de renouveler le mandat de la SRL Deloitte R\u00E9viseurs d\u0027Entreprises (B00025), dont le si\u00E8ge social est situ\u00E9 \u00E0 1930 Zaventem, Luchthaven Brussel Nationaal 1 J, en qualit\u00E9 de commissaire de la soci\u00E9t\u00E9 pour une dur\u00E9e de trois ans et dont le mandat a pris fin \u00E0 l\u0027issue de l"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}10-05-2023 Andrés Calvas appointed as director
- Andrés Calvas, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Andr\u00E9s Calvas",
"address": null,
"birth_date": null
},
"effective_date": "2023-04-12",
"evidence_quote": "Les Actionnaires d\u00E9cident de nommer M. Andr\u00E9s Calvas, domicili\u00E9 \u00E0 10 Avenue Air Marshal Conningham, 1000 Bruxelles, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat et ce pour une dur\u00E9e illimit\u00E9e."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}10-02-2023 Carl Laschet reappointed as statutory auditor
- Carl Laschet, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Carl Laschet",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027entreprises S.C. SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Les adm\u00EDnistrateurs prennent acte du changement de repr\u00E9sentant permanent du comm\u00EDssaire de la Soci\u00E9t\u00E9, \u00E9tant Deloitte R\u00E9viseurs d\u0027entreprises S.C. SRL, qui sera d\u00E9sormais repr\u00E9sent\u00E9e par Carl Laschet, en remplacement de Julie Delforge, et ce r\u00E9troactivement pour l\u0027exercice 2022 et pour le reste de "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}30-05-2022 Patricia Coopmans resigns as director
- Patricia Coopmans, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patricia Coopmans",
"address": null,
"birth_date": null
},
"effective_date": "2022-05-10",
"evidence_quote": "Les Actionnaires d\u00E9cident de mettre fin au mandat, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, de Madame Patricia Coopmans, et ce avec effet au 10 mai 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}13-12-2021 Patricia Coopmans appointed as director
- Patricia Coopmans, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patricia Coopmans",
"address": null,
"birth_date": null
},
"effective_date": "2021-09-13",
"evidence_quote": "Les Actionnaires d\u00E9cident de confier un mandat d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet \u0027au 13 septembre 2021, \u00E0 Madame Patricia Coopmans, domicili\u00E9e \u00E0 1470 Genappe, Baty du Grand Bernard 51."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}06-12-2021 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SRL"
}
}01-02-2021 2 resigning
- Sami Badarani, Bestuurder
- Mathieu Floreani, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sami Badarani",
"address": null,
"birth_date": null
},
"effective_date": "2020-12-15",
"evidence_quote": "Les Actionnaires ont pris note de la d\u00E9mission des administrateurs suivants, avec effet \u00E0 la date des pr\u00E9sentes : -Monsieur Sami Badarani, domicili\u00E9 \u00E0 Germaniastrasse 21, Nr. 042, 80802 Munich - Allemagne;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Mathieu Floreani",
"address": null,
"birth_date": null
},
"effective_date": "2020-12-15",
"evidence_quote": "Les Actionnaires ont pris note de la d\u00E9mission des administrateurs suivants, avec effet \u00E0 la date des pr\u00E9sentes : ... -Monsieur Mathieu Floreani, domicili\u00E9 \u00E0 7206 Ridgewood AV, 20815 Chevy Chase, MD Etats-Unis."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SC"
}
}24-07-2019 End of the company published
Technical details
{
"events": [
{
"date": "2019-07-01",
"kind": "fusie_overgenomen",
"liquidators": [],
"evidence_quote": "Conform\u00E9ment au projet commun d\u0027op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption ... avec effet suspensif sur le plan juridique au 01 juillet 2019 \u00E0 00h\u043E0, l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u0027approuver l\u0027op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption par la pr\u00E9sente soci\u00E9t\u00E9 de la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e \u003C ANALYSES MEDICALES RISSELIN \u00BB ... par voie de transfert par cette derni\u00E8re, par suite de sa dissolution sans liquidation, de l\u0027int\u00E9gralit\u00E9 de son patrimoine actif et passif"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"final_status": "opgeslorpt_door_fusie",
"subject_company": {
"kbo": "0453.111.546"
}
}27-05-2019 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Laurent Dejemeppe",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2019-05-27",
"filing_date": "2019-05-16",
"act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet commun d\u0027op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2019-05-16",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0453.111.546",
"name": "SYNLAB Belgium SPRL",
"role": "acquiring",
"address": "Avenue Alexander Fleming 3, 6220 Heppignies (Fleurus)",
"is_foreign": false,
"legal_form": "SPRL",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0425.310.653",
"name": "Analyses M\u00E9dicales Risselin SPRL",
"role": "absorbed",
"address": "Place de l\u0027H\u00F4tel de Ville 5, 7911 Frasnes-lez-Anvaing",
"is_foreign": false,
"legal_form": "SPRL",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"671",
"676",
"682",
"719",
"720"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": "2017-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "L\u0027ensemble du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e, y compris ses actifs, passifs, droits, obligations et activit\u00E9s op\u00E9rationnelles, sera transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante par transmission universelle.",
"equity_transferred_eur": null,
"accounting_effective_date": "2019-01-01"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB Belgium SPRL",
"legal_form": "SPRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "G\u00E9rard Indekeu et Dimitri Cleenewerck de Crayencour",
"person_name": null,
"org_rep_person_name": "Laurent Dejemeppe"
},
"summary_narrative": "Les soci\u00E9t\u00E9s Analyses M\u00E9dicales Risselin SPRL et SYNLAB Belgium SPRL ont d\u00E9cid\u00E9 de mener une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption, dans laquelle la premi\u00E8re sera absorb\u00E9e par la seconde. Cette op\u00E9ration, fond\u00E9e sur la d\u00E9tention \u00E0 100 % des parts de la soci\u00E9t\u00E9 absorb\u00E9e par la soci\u00E9t\u00E9 absorbante, vise \u00E0 int\u00E9grer les activit\u00E9s op\u00E9rationnelles des deux entit\u00E9s dans une seule entit\u00E9, afin d\u0027optimiser les processus, r\u00E9duire les co\u00FBts et rationaliser la gestion. L\u0027op\u00E9ration sera effective \u00E0 compter du 1er juillet 2019, avec une r\u00E9troactivit\u00E9 comptable \u00E0 partir du 1er janvier 2019.",
"co_filed_documents": [
"Projet commun d\u0027op\u00E9ration assimil\u00E9e \u00E0 la fusion par absorption"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}23-02-2018 1 director appointed, 1 resigning
- Mathieu FLOREANI, Gedelegeerd bestuurder
- Dr. Bartholomaüs WIMMER, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Dr. Bartholoma\u00FCs WIMMER",
"address": null,
"birth_date": null
},
"effective_date": "2017-12-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale prend acte avec effet imm\u00E9diat, au 1 d\u00E9cembre 2017, de la d\u00E9mission de Dr. Bartholoma\u00FCs WIMMER de son mandat de g\u00E9rant de la Soci\u00E9t\u00E9, et le remercie sinc\u00E8rement pour la r\u00E9alisation de son mandat au sein de la Soci\u00E9t\u00E9.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Mathieu FLOREANI",
"address": null,
"birth_date": null
},
"effective_date": "2017-12-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer, avec effet imm\u00E9diat, au 1 d\u00E9cembre 2017, et pour une dur\u00E9e ind\u00E9termin\u00E9e, M. Mathieu FLOREANI \u00E0 la fonction de g\u00E9rant de la Soci\u00E9t\u00E9."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB BELGIUM",
"legal_form": "SC"
}
}19-09-2017 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Dimitri CLEENEWERCK de CRAYENCOUR",
"firm_city": null,
"firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2017-09-19",
"filing_date": "2001-01-30",
"act_kind_objet": "CESSION DE LA BRANCHE D\u0027ACTIVITES \u0022PRESTATIONS DE SERVICES"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2017-08-31",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0441.181.833",
"name": "ELLIPSYS",
"role": "contributor",
"address": "6220 Fleurus, Avenue Alexander Fleming (H) 3",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 en commandite par actions",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0453.111.546",
"name": "SYNLAB Belgium",
"role": "recipient",
"address": "6220 Fleurus, Avenue Alexander Fleming (H) 3",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 civile sous forme de soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"760",
"761",
"762",
"764",
"765",
"766",
"767",
"770",
"81",
"11",
"18 \u00A73"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2017-07-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La cession concerne la branche d\u0027activit\u00E9 \u00AB Prestations de services informatiques \u00BB, incluant le logiciel informatique \u00AB Syst\u00E8me-Expert \u00BB, ses d\u00E9veloppements, bases de donn\u00E9es scientifiques, droits d\u0027auteur, cr\u00E9ances li\u00E9es \u00E0 la licence, et les ressources humaines associ\u00E9es. Les dettes li\u00E9es au financement du d\u00E9veloppement du logiciel sont transf\u00E9r\u00E9es, mais pas les autres dettes.",
"equity_transferred_eur": null,
"accounting_effective_date": "2017-09-01"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB Belgium",
"legal_form": "soci\u00E9t\u00E9 civile sous forme de soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "CMS De Backer",
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "La soci\u00E9t\u00E9 en commandite par actions ELLIPSYS a c\u00E9d\u00E9 \u00E0 titre on\u00E9reux, \u00E0 la soci\u00E9t\u00E9 civile sous forme de soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e SYNLAB Belgium, la branche d\u0027activit\u00E9 \u00AB Prestations de services informatiques \u00BB, incluant le logiciel \u00AB Syst\u00E8me-Expert \u00BB, ses droits d\u0027auteur, bases de donn\u00E9es scientifiques, cr\u00E9ances li\u00E9es \u00E0 la licence, et deux employ\u00E9s. La cession est effective au 1er septembre 2017, conform\u00E9ment aux articles 760 \u00E0 767 du Code des soci\u00E9t\u00E9s et au r\u00E9gime d\u0027exon\u00E9ration de la TVA. Les parties ont d\u00E9pos\u00E9 un projet de cession au greffe le 19 juillet 2017.",
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procuration"
],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}31-07-2017 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "G\u00E9rard INDEKEU",
"firm_city": null,
"firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2017-07-31",
"filing_date": "2017-07-18",
"act_kind_objet": "PROJET COMMUN DE CESSION \u00E0 titre on\u00E9reux de la branche d\u0027activit\u00E9"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2017-07-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0441.181.833",
"name": "ELLIPSYS",
"role": "contributor",
"address": "6220 Fleurus, Avenue Alexander Fleming (H) 3",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 commandite par actions",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0453.111.546",
"name": "SYNLAB Belgium",
"role": "recipient",
"address": "6220 Fleurus, Avenue Alexander Fleming (H) 3",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 civile sous forme de soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"760",
"761",
"762",
"764",
"765",
"766",
"767",
"770"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La branche d\u0027activit\u00E9 \u00AB Prestations de Services Informatiques \u00BB comprend les ressources humaines (2 personnes), le logiciel informatique \u00AB Syst\u00E8me-Expert \u00BB, ses d\u00E9veloppements, am\u00E9liorations, bases de donn\u00E9es scientifiques, droits d\u0027auteur, cr\u00E9ances li\u00E9es \u00E0 la licence du logiciel, et dettes li\u00E9es au financement de son d\u00E9veloppement.",
"equity_transferred_eur": null,
"accounting_effective_date": "2017-09-01"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "SYNLAB Belgium",
"legal_form": "Soci\u00E9t\u00E9 civile sous forme de soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0890.388.338",
"org_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
"person_name": null,
"org_rep_person_name": "G\u00E9rard INDEKEU"
},
"summary_narrative": "Le g\u00E9rant de ELLIPSYS et les g\u00E9rants de SYNLAB Belgium ont d\u00E9cid\u00E9 de c\u00E9der \u00E0 titre on\u00E9reux la branche d\u0027activit\u00E9 \u00AB Prestations de Services Informatiques \u00BB \u00E0 SYNLAB Belgium, conform\u00E9ment aux articles 760 \u00E0 767 du Code des soci\u00E9t\u00E9s. Cette cession, qui inclut le logiciel \u00AB Syst\u00E8me-Expert \u00BB, ses droits d\u0027auteur, les ressources humaines d\u00E9di\u00E9es, et les cr\u00E9ances li\u00E9es \u00E0 sa licence, s\u0027inscrit dans une strat\u00E9gie de rationalisation interne du groupe. L\u0027effet comptable et fiscal est pr\u00E9vu \u00E0 compter du 1er septembre 2017.",
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procurations"
],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}27-07-2017 Capital increase of €168,895.68 to €437,495.68
- €268.600 → €437.495,68
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 168895.68,
"currency": "EUR",
"after_eur": 437495.68,
"delta_eur": 168895.68,
"before_eur": 268600.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2017-07-01",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital social \u00E0 concurrence de 168.895,68 euros, pour porter le capital social de celle-ci de 268.600,00 euros \u00E0 un montant de 437.495,68 euros",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}30-06-2017 Julie Delforge appointed as statutory auditor
- Julie Delforge, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SCRL Deloitte R\u00E9viseurs d\u0027entreprises",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2016-06-24",
"evidence_quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale de la Soci\u00E9t\u00E9 a nomm\u00E9 la SCRL Deloitte R\u00E9viseurs d\u0027entreprises, repr\u00E9sent\u00E9e par Julie Delforge, comme commissaire de la Soci\u00E9t\u00E9 pour un mandat de 3 ans prenant cours le 24 juin 2016."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}06-06-2017 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}30-05-2017 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "St\u00E9phane Collin",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2017-05-30",
"filing_date": "2017-05-18",
"act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet commun de fusion par absorption"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2017-05-16",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "Les associ\u00E9s des soci\u00E9t\u00E9s parties \u00E0 la fusion ont renonc\u00E9, \u00E0 l\u0027unanimit\u00E9, \u00E0 la mise \u00E0 disposition des rapports sp\u00E9ciaux \u00E9tablis par les g\u00E9rants et les commissaires, conform\u00E9ment aux articles 694, 695 et 696 du Code des soci\u00E9t\u00E9s.",
"articles": [
"694",
"695",
"696"
]
},
"restructuring": {
"parties": [
{
"kbo": "0440.299.628",
"name": "Laboratoire d\u0027Analyses M\u00E9dicales Roman Pa\u00EFs SC SPRL",
"role": "absorbed",
"address": "1400 Nivelles, Rue Seutin 11",
"is_foreign": false,
"legal_form": "SC SPRL",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0453.111.546",
"name": "Laboratoire d\u0027Analyses M\u00E9dicales Dr. J. Collard SC SPRL",
"role": "acquiring",
"address": "4800 Verviers, Rue du Palais 14",
"is_foreign": false,
"legal_form": "SC SPRL",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.9,
"legal_articles": [
"12:7",
"12:50",
"671",
"682",
"693",
"694",
"695",
"696",
"697 \u00A72"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2016-12-31",
"exchange_ratio_text": "10 parts de la Soci\u00E9t\u00E9 absorb\u00E9e seront \u00E9chang\u00E9es contre 9 parts de la Soci\u00E9t\u00E9 absorbante",
"new_shares_issued_n": 786,
"real_estate_included": false,
"patrimony_description": "L\u0027ensemble du patrimoine actif et passif, y compris les droits, engagements, obligations, biens immobiliers, droits de propri\u00E9t\u00E9 intellectuelle, licences, contrats de travail, baux, participations dans des soci\u00E9t\u00E9s tierces, et engagements hors bilan de la soci\u00E9t\u00E9 absorb\u00E9e est transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante.",
"equity_transferred_eur": 21690.68,
"accounting_effective_date": "2017-01-01"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "Laboratoire d\u0027Analyses M\u00E9dicales Dr. J. Collard SC SPRL",
"legal_form": "SC SPRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "CMS DeBacker",
"person_name": null,
"org_rep_person_name": "St\u00E9phane Collin"
},
"summary_narrative": "Le projet de fusion par absorption a \u00E9t\u00E9 \u00E9tabli le 16 mai 2017 par les g\u00E9rants des soci\u00E9t\u00E9s Laboratoire d\u0027Analyses M\u00E9dicales Roman Pa\u00EFs SC SPRL (absorb\u00E9e) et Laboratoire d\u0027Analyses M\u00E9dicales Dr. J. Collard SC SPRL (absorbante). L\u0027op\u00E9ration, qui prendra effet le 1er juillet 2017, vise \u00E0 int\u00E9grer les activit\u00E9s de biologie clinique, d\u0027anatomie pathologique et de biologie nutritionnelle de la soci\u00E9t\u00E9 absorb\u00E9e dans la soci\u00E9t\u00E9 absorbante. Le rapport d\u0027\u00E9change est fix\u00E9 \u00E0 0,9, et 786 nouvelles parts seront \u00E9mises. L\u0027op\u00E9ration s\u0027inscrit dans une r\u00E9organisation plus large du groupe SYNLAB en Belgique.",
"co_filed_documents": [
"D\u00E9p\u00F4t du projet de fusion au greffe du Tribunal de commerce de Li\u00E8ge, Division Verviers"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}13-08-2015 Capital increase of €18,600 to €268,600
- €250.000 → €268.600
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 18600,
"currency": "EUR",
"after_eur": 268600,
"delta_eur": 18600,
"before_eur": 250000,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-06-26",
"evidence_quote": "a d\u00E9cid\u00E9 d\u0027augmenter le capital social, \u00E0 concurrence de 18.600 euros pour le porter de 250.000 euros \u00E0 268.600 euros par la cr\u00E9ation de 250 parts sociales nouvelles",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}02-02-2015 2 directors appointed
- Olivier Collard, Gedelegeerd bestuurder
- Antonio di Cintio, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Olivier Collard",
"address": null,
"birth_date": null
},
"effective_date": "2014-12-31",
"evidence_quote": "Les associ\u00E9s de la Soci\u00E9t\u00E9 approuvent la nomination des personnes suivantes en qualit\u00E9 de g\u00E9rants de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e illimit\u00E9e: -Monsieur Olivier Collard"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Antonio di Cintio",
"address": null,
"birth_date": null
},
"effective_date": "2014-12-31",
"evidence_quote": "Les associ\u00E9s de la Soci\u00E9t\u00E9 approuvent la nomination des personnes suivantes en qualit\u00E9 de g\u00E9rants de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e illimit\u00E9e: -Monsieur Antonio di Cintio"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}06-01-2015 2 directors appointed
- Antoine Lejeune, Gedelegeerd bestuurder
- Henri Pirenne, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Antoine Lejeune",
"address": null,
"birth_date": null
},
"effective_date": "2014-11-30",
"evidence_quote": "Les associ\u00E9s de la Soci\u00E9t\u00E9 approuvent la nomination des personnes suivantes en qualit\u00E9 de g\u00E9rants de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e illimit\u00E9e: -Monsieur Antoine Lejeune"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Henri Pirenne",
"address": null,
"birth_date": null
},
"effective_date": "2014-11-30",
"evidence_quote": "Les associ\u00E9s de la Soci\u00E9t\u00E9 approuvent la nomination des personnes suivantes en qualit\u00E9 de g\u00E9rants de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e illimit\u00E9e: -Monsieur Henri Pirenne"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}21-08-2013 End of the company published
Technical details
{
"events": [
{
"date": "2013-07-01",
"kind": "fusie_overgenomen",
"liquidators": [],
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de fusionner la pr\u00E9sente soci\u00E9t\u00E9 par absorption... de la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e \u003C\u003C BIOSEMOIS \u00BB... laquelle soci\u00E9t\u00E9 absorb\u00E9e transf\u00E8re, par suite de sa dissolution sans liquidation, l\u0027int\u00E9gralit\u00E9 de son patrimoine activement et passivement \u00E0 la pr\u00E9sente soci\u00E9t\u00E9, avec effet juridique au premier juillet deux mil treize \u00E0 z\u00E9ro heure."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"final_status": "opgeslorpt_door_fusie",
"subject_company": {
"kbo": "0453.111.546"
}
}14-08-2013 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}29-07-2013 1 director appointed, 1 resigning
- Marie-Laure Moreau, Commissaris
- Michel Grignard, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Michel Grignard",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-05-26",
"evidence_quote": "Le mandat du commissaire BDO R\u00E9viseurs d\u0027Entreprises, repr\u00E9sent\u00E9 par Michel Grignard est arriv\u00E9 \u00E0 expiration le 26 mai 2013."
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Marie-Laure Moreau",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Ernst \u0026 Young Bedrijfsrevisoren BCVBA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-06-28",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat Ernst \u0026 Young Bedrijfsrevisoren BCVBA, repr\u00E9sent\u00E9e par Madame Marie-Laure Moreau pour une dur\u00E9e de trois ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}13-03-2013 1 director appointed, 1 reappointed
- Robert Steinwander, Gedelegeerd bestuurder
- Bartl Wimmer, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Robert Steinwander",
"address": null,
"birth_date": null
},
"effective_date": "2013-02-21",
"evidence_quote": "L\u0027associ\u00E9 unique de la Soci\u00E9t\u00E9 d\u00E9cide de nommer M. Robert Steinwander, de nationalit\u00E9 autrichienne, demeurant \u00E0 Maistra\u00DFe 41, 80337 Munich, Allemagne, en qualit\u00E9 de g\u00E9rant de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e de illimit\u00E9e."
},
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Bartl Wimmer",
"address": null,
"birth_date": null
},
"effective_date": "2013-02-21",
"evidence_quote": "L\u0027associ\u00E9 unique souhaite modifier la dur\u00E9e du mandat de g\u00E9rant de Dr. Bartl Wimmer, et d\u00E9cide que Dr. Bartl Wimmer est nomm\u00E9 g\u00E9rant de la Soci\u00E9t\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9e."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}07-02-2013 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2013-01-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}23-01-2013 1 director appointed, 1 resigning
- Dr. Bart Wimmer, Gedelegeerd bestuurder
- Gabriel Habib, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Gabriel Habib",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0823974616",
"name": "Habilis Management \u0026 Real Estate SPRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2012-12-21",
"evidence_quote": "L\u0027associ\u00E9 unique de la Soci\u00E9t\u00E9 prend acte de la d\u00E9mission avec effet imm\u00E9diat de Habilis Management \u0026 Real Estate SPRL, en abr\u00E9g\u00E9 Habilis, dont le si\u00E8ge social se situe \u00E0 4020 Li\u00E8ge (Belgique), Rue de la Justice 13, et inscrite au registre des personnes morales de Li\u00E8ge sous le num\u00E9ro 823.974.616, r"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Dr. Bart Wimmer",
"address": null,
"birth_date": null
},
"effective_date": "2012-12-21",
"evidence_quote": "L\u0027associ\u00E9 unique de la Soci\u00E9t\u00E9 approuve la nomination de Dr. Bart! Wimmer, de nationalit\u00E9 allemande, demeurant \u00E0 Doktorberg 15, D-83471 Berchtesgaden, en qualit\u00E9 de g\u00E9rant de la Soci\u00E9t\u00E9, et ce avec effet imm\u00E9diat et pour une dur\u00E9e de 10 (dix) ann\u00E9es."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}10-12-2012 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2012-11-30",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}28-07-2011 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0453.111.546",
"name_full": "LABORATOIRE D\u0027ANALYSES MEDICALES DR. J. COLLARD",
"legal_form": "SC"
}
}| Legal nameFR | SYNLAB Belgium |